272 related articles for article (PubMed ID: 33780078)
1. Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis.
Li W; Lu H; Wang H; Hu L; Sun X; Yu H; Wang D
Head Neck; 2021 Aug; 43(8):2353-2363. PubMed ID: 33780078
[TBL] [Abstract][Full Text] [Related]
2. Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases.
Lin C; Sun XS; Liu SL; Li XY; Lu N; Li XL; Tang LQ; Guo L
Cancer Res Treat; 2020 Jul; 52(3):855-866. PubMed ID: 32164051
[TBL] [Abstract][Full Text] [Related]
3. Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.
Zuo H; Li MM
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15969-15987. PubMed ID: 37684510
[TBL] [Abstract][Full Text] [Related]
4. Significance of radiologic extranodal extension in locoregionally advanced nasopharyngeal carcinoma with lymph node metastasis: a comprehensive nomogram.
Ding J; Chen J; Lin Y; Hong J; Huang C; Fei Z; Chen C
Braz J Otorhinolaryngol; 2024; 90(2):101363. PubMed ID: 38101121
[TBL] [Abstract][Full Text] [Related]
5. Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up.
Sun XS; Li XY; Xiao BB; Liu SL; Chen QY; Tang LQ; Mai HQ
Oral Oncol; 2020 Jan; 100():104490. PubMed ID: 31790913
[TBL] [Abstract][Full Text] [Related]
6. A novel nomogram to predict survival in patients with recurrent nasopharyngeal carcinoma after salvage endoscopic surgery.
Li W; Lu H; Liu J; Liu Q; Wang H; Zhang H; Hu L; Zhao W; Gu Y; Li H; Sun X; Wang D
Oral Oncol; 2020 Dec; 111():104922. PubMed ID: 32712576
[TBL] [Abstract][Full Text] [Related]
7. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
[TBL] [Abstract][Full Text] [Related]
8. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
[TBL] [Abstract][Full Text] [Related]
9. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
[TBL] [Abstract][Full Text] [Related]
10. Novel nomograms to predict lymph node metastasis and liver metastasis in patients with early colon carcinoma.
Yan Y; Liu H; Mao K; Zhang M; Zhou Q; Yu W; Shi B; Wang J; Xiao Z
J Transl Med; 2019 Jun; 17(1):193. PubMed ID: 31182111
[TBL] [Abstract][Full Text] [Related]
11. Regional lymph node density-based nomogram predicts prognosis in nasopharyngeal carcinoma patients without distant metastases.
Ma J; Zhao R; Wu YL; Liu Y; Jin GQ; Su DK
Cancer Imaging; 2023 Dec; 23(1):123. PubMed ID: 38102725
[TBL] [Abstract][Full Text] [Related]
12. Nomogram to Predict Long-Term Overall Survival and Cancer-Specific Survival of Radiotherapy Patients with Nasopharyngeal Carcinoma.
Li Z; Li C; Yang D; Zhou Z; Kang M
Biomed Res Int; 2023; 2023():7126881. PubMed ID: 36704722
[TBL] [Abstract][Full Text] [Related]
13. Early distinction of lymph node metastasis in patients with soft tissue sarcoma and individualized survival prediction using the online available nomograms: A population-based analysis.
Tong Y; Pi Y; Cui Y; Jiang L; Gong Y; Zhao D
Front Oncol; 2022; 12():959804. PubMed ID: 36568161
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
[TBL] [Abstract][Full Text] [Related]
15. A prognostic nomogram incorporating tumor size and lymph node size for patients with nasopharyngeal carcinoma.
Yi Q; Cai J; Lin Y; Hu Z; Lin J; Huang Z; Liu W; Zheng R; Yuan Y; Chen C
Am J Otolaryngol; 2023; 44(2):103717. PubMed ID: 36516528
[TBL] [Abstract][Full Text] [Related]
16. Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.
Tang LQ; Li CF; Li J; Chen WH; Chen QY; Yuan LX; Lai XP; He Y; Xu YX; Hu DP; Wen SH; Peng YT; Zhang L; Guo SS; Liu LT; Guo L; Wu YS; Luo DH; Huang PY; Mo HY; Xiang YQ; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Cao KJ; Qian CN; Guo X; Zeng YX; Mai HQ; Zeng MS
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26467665
[TBL] [Abstract][Full Text] [Related]
17. Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.
Li S; Wang Y; Hu X
Cancer Med; 2023 Mar; 12(6):6853-6866. PubMed ID: 36479835
[TBL] [Abstract][Full Text] [Related]
18. Developing a nomogram model and prognostic analysis of nasopharyngeal squamous cell carcinoma patients: a population-based study.
Liu K; Wang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12165-12175. PubMed ID: 37428250
[TBL] [Abstract][Full Text] [Related]
19. A practical nomogram from the SEER database to predict the prognosis of hepatocellular carcinoma in patients with lymph node metastasis.
Zhang K; Tao C; Wu F; Wu J; Rong W
Ann Palliat Med; 2021 Apr; 10(4):3847-3863. PubMed ID: 33752423
[TBL] [Abstract][Full Text] [Related]
20. MRI-identified multidimensional nodal features predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma.
Liu Y; Zhang J; Wang J; Wu R; Huang X; Wang K; Qu Y; Chen X; Li Y; Zhang Y; Yi J
Radiol Oncol; 2022 Dec; 56(4):479-487. PubMed ID: 36503717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]